EX-99.1 2 d98492dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Appendix 4C Quarterly report for entities

admitted on the basis of commitments

Appendix 4C – 4th Quarter

Quarterly Report

For Entities Admitted on the Basis of Commitments

Introduced 31/3/2000. Amended 30/9/2001

Name of Entity:

 

Prima BioMed Ltd

   (ASX:PRR)     

 

ABN:

    Quarter Ended (“Current Quarter”)

90 009 237 889

    30 June 2015

Consolidated Statement of Cash Flows

 

       Current Quarter         Year-to-Date   

         Cash flows related to operating activities

     $A’000         $A’000   

1.1      Receipts from customers

     114         5,889   

1.2      Payments for

         

(a) staff costs

     (953      (3,644

(b) advertising and marketing

     (44      (278

(c) research and development

     (1,210      (8,112

(d) leased assets

               

(e) other working capital

     (809      (2,594

1.3      Dividends received

               

1.4      Interest and other items of a similar nature received

     8         344   

1.5      Interest and other costs of finance paid

               

1.6      Income taxes expense

               

1.7      Other – (R&D tax refund, grants received)

     329         1,503   

Net operating cash flows

     (2,565      (6,892

 

+ See chapter 19 for defined terms.

30/9/2001

   Appendix 4C Page 1


Appendix 4C Quarterly report for entities

admitted on the basis of commitments

 

      

 

Current Quarter

$A’000

  

  

    

 

Year-to-Date

$A’000

  

  

1.8      Net operating cash flows (carried forward)

     (2,565      (6,892

Cash flows related to investing activities

                 

1.9      Payment for acquisition of:

     (5,081      (20,877

(a) businesses (item 5)

         

(b) equity investments

               

(c) intellectual property

               

(d) physical non-current assets

             (46

(e) other non-current assets

               

1.10    Proceeds from disposal of:

         

(a) businesses (item 5)

               

(b) equity investments

               

(c) intellectual property

               

(d) physical non-current assets

               

(e) other non-current assets

               

1.11    Loans to other entities

               

1.12    Loans repaid by other entities

               

1.13    Other (provide details if material)

               

Net investing cash flows

     (5,081      (20,923

1.14    Total operating and investing cash flows

     (7,646      (27,815

Cash flows related to financing activities

                 

1.15    Proceeds from issues of shares, options, etc.

     6,394         7,758   

1.16    Transfer of shares

               

1.17    Proceeds from borrowings net finance costs

             2,854   

1.18    Repayment of borrowings

             (212

1.19    Dividends paid

               

1.20    Other—capital raising costs

     (67      (78

Net financing cash flows

     6,327         10,322   

Net increase (decrease) in cash held

     (1,319      (17,493

1.21    Cash at beginning of quarter/year to date

     8,010         23,200   

1.22    Exchange rate adjustments to item 1.21

     69         1,053   

1.23    Cash at end of quarter

     6,760         6,760   

 

+ See chapter 19 for defined terms.

30/9/2001

   Appendix 4C Page 2


Appendix 4C Quarterly report for entities

admitted on the basis of commitments

Payments to Directors of the Entity and Associates of the Directors

Payments to Related Entities of the Entity and Associates of the Related Entities

 

         

 

Current Quarter

$A’000

  

  

1.24

  Aggregate amount of payments to the parties included in item 1.2         220   

1.25

  Aggregate amount of loans to the parties included in item 1.11           

1.26

  Explanation necessary for an understanding of the transactions      
  Directors’ fees and consulting fees at normal commercial rates   

Non-Cash Financing and Investing Activities

     

2.1

  Details of financing and investing transactions which have had a material effect on consolidated Assets and liabilities but did not involve cash flows       
 

Issued 22,936,950 ordinary shares in relation to the Bergen funding agreement.

 

  

  Convertible note converted into 166,097,263 ordinary shares at the election of Bergen under the terms of the Bergen funding agreement.    

2.2

  Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest       
     

Financing Facilities Available

     
  Add notes as necessary for an understanding of the position. (See AASB 1026 paragraph 12.2).   
      

 

Amount Available

$A’000

  

  

    

 

Amount Used

$ A’000

  

  

3.1

  Loan facilities (*1)                

3.2

  Credit standby arrangements                

 

+ See chapter 19 for defined terms.

30/9/2001

   Appendix 4C Page 3


Appendix 4C Quarterly report for entities

admitted on the basis of commitments

 

Reconciliation of Cash

     
   Reconciliation of cash at the end of the quarter
(as shown in the consolidated statement of cash flows)
to the related items in the accounts is as follows.
    
 

 

Current
Quarter

$A’000

  
  

  

    

 

 

Previous

Quarter

$A’000

  

  

  

4.1

   Cash on hand and at bank      3,781         7,204   

4.2

   Deposits at call      2,729         556   

4.3

   Bank overdraft                

4.4

   Other (Term Deposit)      250         250   
   Total: Cash at end of quarter (item 1.23)      6,760         8,010   

Acquisitions and Disposals of Business Entities

     
       
 
Acquisitions
(Item 1.9(a))
  
  
    
 
Disposals
(Item 1.10(a))
  
  

5.1

   Name of entity                

5.2

   Place of incorporation or registration                

5.3

   Consideration for acquisition or disposal                

5.4

   Total net assets                

5.5

   Nature of business                

Compliance Statement

     

1

   This statement has been prepared under accounting policies which comply with accounting standards as defined in the Corporations Act (except to the extent that information is not required because of note 2) or other standards acceptable to ASX.     

2

   This statement does give a true and fair view of the matters disclosed.   

 

Sign Here:

      Date: Tuesday 28th July 2015
   LOGO   
   Company Secretary   
Print Name:    Deanne Miller   

 

+ See chapter 19 for defined terms.

30/9/2001

   Appendix 4C Page 4


Appendix 4C Quarterly report for entities

admitted on the basis of commitments

Notes

 

1. The quarterly report provides a basis for informing the market how the entity’s activities have been financed for the past quarter and the effect on its cash position. An entity wanting to disclose additional information is encouraged to do so, in a note or notes attached to this report.

 

2. The definitions in, and provisions of, AASB 1026: Statement of Cash Flows apply to this report except for the paragraphs of the Standard set out below.

 

    6.2 - reconciliation of cash flows arising from operating activities to operating profit or loss

 

    9.2 - itemised disclosure relating to acquisitions

 

    9.4 - itemised disclosure relating to disposals

 

    12.1(a) - policy for classification of cash items

 

    12.3 - disclosure of restrictions on use of cash

 

    13.1 - comparative information

 

3. Accounting Standards. ASX will accept, for example, the use of International Accounting Standards for foreign entities. If the standards used do not address a topic, the Australian standard on that topic (if any) must be complied with.

 

+ See chapter 19 for defined terms.

30/9/2001

   Appendix 4C Page 5